Ariadne Expands Presence in South-East Asia

Genomax Technologies to Distribute Ariadne Software in the Region

20-Oct-2006

Ariadne genomics, Inc. announced that is has signed a distributor agreement with Genomax Technologies Pte. Ltd. (Singapore) to represent Ariadne products in South-East Asia. Genomax will be distributing and supporting Ariadne pathway analysis software to life scientists in Singapore, Malaysia and Thailand.

"We are glad that Genomax has joined Ariadne sales team", said John Clouston, Sales Manager at Ariadne. "Genomax is a key supplier for the life science research in South-East Asia, specifically focused on the areas of genomics, proteomics, molecular and cell biology, and we expect this relationship to be long and prosperous".

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Last viewed contents

Hidden RNA repair mechanism discovered in humans - Function of a previously uncharacterized human protein elucidated

Hidden RNA repair mechanism discovered in humans - Function of a previously uncharacterized human protein elucidated

Experience leads to the growth of new brain cells - A new study examines how individuality develops

Experience leads to the growth of new brain cells - A new study examines how individuality develops

Enzo rejects Roche settlement offer - Roche responds with lawsuit

Cold Spring Biotech Corp. to Distribute Strand Genomics' avadis in Taiwan

Syngenta files suit to enforce biotechnology patents

MediGene Receives New US Patent for Cancer-Killing Viruses - Patent protects herpes simplex viruses (HSV) genetically modified to activate the immune system against tumor cells

YM Bioscience reports Phase II data for nimotuzumab in metastatic colorectal cancer - Overall Survival And Disease Control Outcomes, Coupled With Low Toxicity, Support The Continued Development Of The EGFR Antibody In Patients With Colorectal Cancer

SYGNIS completes acquisition of TGR Biosciences

Chemist developed a green catalyst for pharmaceutical and industrial chemistry - Catalyst based on a substance that comes from plant waste

Chemist developed a green catalyst for pharmaceutical and industrial chemistry - Catalyst based on a substance that comes from plant waste

Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics - Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing

Celera Genomics Presents Preclinical Data on its Human Histone Deacetylase (HDAC) Inhibitor

Seaweed offers the solution to transporting stem cells and wound treatment

Seaweed offers the solution to transporting stem cells and wound treatment